Strides: Strides Pharma debuts with ESG rating of 76/100 in the S&P Global's CSA 2024
Scored 85/100, 2.3x the industry average in Social and 73/100, 1.8x the industry average in Governance
Read full article »
CEO
- -Strides is a pharmaceutical company that develops and commercializes soft gelatin capsules for the healthcare industry.
Read more